Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Apr;76(4):325–329. doi: 10.1136/adc.76.4.325

Inflammatory bowel disease and predisposition to osteopenia

F Cowan 1, J Warner 1, F Dunstan 1, W Evans 1, J Gregory 1, H Jenkins 1
PMCID: PMC1717165  PMID: 9166024

Abstract

Accepted 13 December 1996


The prevalence of osteopenia in children with inflammatory bowel disease (IBD) is unknown. The effect of nutritional state, disease activity, and steroid therapy on bone mineral content (BMC) of whole body, lumbar spine, and left femoral neck measured by dual energy x ray absorptiometry in 32 children with IBD was assessed by comparison with 58 healthy local school children. Using the control data, a predicted BMC was calculated taking into account bone area, age, height, weight, and pubertal stage. The measured BMC in children with IBD was expressed as a percentage of this predicted value (% BMC). Mean (SD) % BMC was significantly reduced for the whole body and left femoral neck in the children with IBD (97.0 (4.5)% and 93.1 (12.0)% respectively, p<0.05). Of the children with IBD, 41% had a % BMC less than 1 SD below the mean for the whole body and 47% at the femoral neck. Reduction in % BMC was associated with steroid usage but not with the magnitude of steroid dose, disease activity, or biochemical markers of bone metabolism. In conclusion, osteopenia is relatively common in childhood IBD and may be partly related to the previous use of steroids.



Full Text

The Full Text of this article is available as a PDF (109.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abitbol V., Roux C., Chaussade S., Guillemant S., Kolta S., Dougados M., Couturier D., Amor B. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995 Feb;108(2):417–422. doi: 10.1016/0016-5085(95)90068-3. [DOI] [PubMed] [Google Scholar]
  2. Bernstein C. N., Seeger L. L., Sayre J. W., Anton P. A., Artinian L., Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 1995 Feb;10(2):250–256. doi: 10.1002/jbmr.5650100211. [DOI] [PubMed] [Google Scholar]
  3. Boot A. M., Nauta J., Hokken-Koelega A. C., Pols H. A., de Ridder M. A., de Muinck Keizer-Schrama S. M. Renal transplantation and osteoporosis. Arch Dis Child. 1995 Jun;72(6):502–506. doi: 10.1136/adc.72.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brook C. G. Determination of body composition of children from skinfold measurements. Arch Dis Child. 1971 Apr;46(246):182–184. doi: 10.1136/adc.46.246.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clements D., Motley R. J., Evans W. D., Harries A. D., Rhodes J., Coles R. J., Compston J. E. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol. 1992 Dec;27(12):1055–1060. doi: 10.3109/00365529209028138. [DOI] [PubMed] [Google Scholar]
  6. Cole T. J., Freeman J. V., Preece M. A. Body mass index reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):25–29. doi: 10.1136/adc.73.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Compston J. E. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther. 1995 Jun;9(3):237–250. doi: 10.1111/j.1365-2036.1995.tb00378.x. [DOI] [PubMed] [Google Scholar]
  8. Cowan F. J., Parker D. R., Jenkins H. R. Osteopenia in Crohn's disease. Arch Dis Child. 1995 Sep;73(3):255–256. doi: 10.1136/adc.73.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Croucher P. I., Vedi S., Motley R. J., Garrahan N. J., Stanton M. R., Compston J. E. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int. 1993 Sep;3(5):236–241. doi: 10.1007/BF01623826. [DOI] [PubMed] [Google Scholar]
  10. Durnin J. V., Rahaman M. M. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr. 1967 Aug;21(3):681–689. doi: 10.1079/bjn19670070. [DOI] [PubMed] [Google Scholar]
  11. Freeman J. V., Cole T. J., Chinn S., Jones P. R., White E. M., Preece M. A. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):17–24. doi: 10.1136/adc.73.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fries W., Giacomin D., Plebani M., Martin A. Effect of experimental colitis on bone metabolism in the rat. Digestion. 1994;55(4):229–233. doi: 10.1159/000201152. [DOI] [PubMed] [Google Scholar]
  13. Ghosh S., Cowen S., Hannan W. J., Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology. 1994 Oct;107(4):1031–1039. doi: 10.1016/0016-5085(94)90227-5. [DOI] [PubMed] [Google Scholar]
  14. Gärdsell P., Johnell O., Nilsson B. E. The predictive value of forearm bone mineral content measurements in men. Bone. 1990;11(4):229–232. doi: 10.1016/8756-3282(90)90074-9. [DOI] [PubMed] [Google Scholar]
  15. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  16. Hildebrand H., Karlberg J., Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994 Feb;18(2):165–173. doi: 10.1097/00005176-199402000-00008. [DOI] [PubMed] [Google Scholar]
  17. Kelts D. G., Grand R. J., Shen G., Watkins J. B., Werlin S. L., Boehme C. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterology. 1979 Apr;76(4):720–727. [PubMed] [Google Scholar]
  18. Kinberg K. A., Hopp R. J., Biven R. E., Gallagher J. C. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol. 1994 Sep;94(3 Pt 1):490–497. doi: 10.1016/0091-6749(94)90205-4. [DOI] [PubMed] [Google Scholar]
  19. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am. 1994 Aug;20(3):629–650. [PubMed] [Google Scholar]
  20. Martinati L. C., Bertoldo F., Gasperi E., Micelli S., Boner A. L. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med. 1996 Jan;153(1):232–236. doi: 10.1164/ajrccm.153.1.8542121. [DOI] [PubMed] [Google Scholar]
  21. Motil K. J., Grand R. J., Davis-Kraft L., Ferlic L. L., Smith E. O. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993 Sep;105(3):681–691. doi: 10.1016/0016-5085(93)90883-e. [DOI] [PubMed] [Google Scholar]
  22. Motley R. J., Clements D., Evans W. D., Crawley E. O., Evans C., Rhodes J., Compston J. E. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner. 1993 Nov;23(2):95–104. doi: 10.1016/s0169-6009(08)80046-3. [DOI] [PubMed] [Google Scholar]
  23. Polito C., Strano C. G., Rea L., Alessio M., Iammarrone C. S., Todisco N., Marotta A., Iaccarino E., Pirozzi M. Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis. Ann Rheum Dis. 1995 Mar;54(3):193–196. doi: 10.1136/ard.54.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Prentice A., Parsons T. J., Cole T. J. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr. 1994 Dec;60(6):837–842. doi: 10.1093/ajcn/60.6.837. [DOI] [PubMed] [Google Scholar]
  25. Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Scharla S. H., Minne H. W., Lempert U. G., Leidig G., Hauber M., Raedsch R., Ziegler R. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol. 1994;102(1):44–49. doi: 10.1055/s-0029-1211264. [DOI] [PubMed] [Google Scholar]
  27. Shaw N. J., Bishop N. J. Mineral accretion in growing bones--a framework for the future? Arch Dis Child. 1995 Feb;72(2):177–179. doi: 10.1136/adc.72.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Silvennoinen J. A., Karttunen T. J., Niemelä S. E., Manelius J. J., Lehtola J. K. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995 Jul;37(1):71–76. doi: 10.1136/gut.37.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med. 1996 Feb;239(2):131–137. doi: 10.1046/j.1365-2796.1996.420765000.x. [DOI] [PubMed] [Google Scholar]
  30. Slemenda C. W., Miller J. Z., Hui S. L., Reister T. K., Johnston C. C., Jr Role of physical activity in the development of skeletal mass in children. J Bone Miner Res. 1991 Nov;6(11):1227–1233. doi: 10.1002/jbmr.5650061113. [DOI] [PubMed] [Google Scholar]
  31. Svendsen O. L., Haarbo J., Hassager C., Christiansen C. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. Am J Clin Nutr. 1993 May;57(5):605–608. doi: 10.1093/ajcn/57.5.605. [DOI] [PubMed] [Google Scholar]
  32. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES